Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse...

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Toll-like Receptors (TLRs) are implicated in the proliferation of splenic marginal zone lymphoma (SMZL).
• Splenic diffuse red pulp lymphoma (SDRPL) is a distinct but related entity to SMZL, necessitating comparative analysis of their immunological features.
• Understanding TLR patterns in these lymphomas can reveal insights into their pathogenesis and potential diagnostic markers.

Purpose of the Study:

• To compare the Toll-like Receptor (TLR) profiles and functionality in splenic marginal zone lymphoma (SMZL) and splenic diffuse red pulp lymphoma (SDRPL).
• To investigate the expression of TLR7, TLR9, CD80, and CD86 in B cells from patients with SMZL and SDRPL.
• To assess the impact of TLR7 and TLR9 stimulation on the proliferation and apoptosis of SMZL and SDRPL B cells.

Main Methods:

• Flow cytometry was used to analyze the expression of TLR7, TLR9, CD80, and CD86 on B cells from SMZL and SDRPL patients.
• In vitro stimulation assays with TLR7 and TLR9 agonists were performed to assess pathway functionality by measuring IL-6 production.
• Proliferation and apoptosis assays were conducted following TLR stimulation to evaluate cellular responses.

Main Results:

• SDRPL B cells demonstrated higher expression of TLR7 and TLR9 compared to SMZL B cells.
• Both TLR7 and TLR9 pathways were functional in both lymphoma subtypes, indicated by IL-6 production.
• Circulating SDRPL B cells constitutively expressed CD86 and showed increased CD80 expression upon TLR7 and TLR9 stimulation, unlike SMZL B cells.
• TLR7 and TLR9 stimulation did not affect the proliferation or apoptosis of either SMZL or SDRPL B cells.

Conclusions:

• SMZL and SDRPL possess distinct TLR profiles and immunological features.
• The observed differences in TLR expression and associated markers (CD80, CD86) suggest distinct origins from different splenic memory B cells.
• These specific immunological features hold potential as diagnostic markers for differentiating SMZL and SDRPL in peripheral blood samples.